NEW YORK, NY, HistoWiz, a leading digital histopathology service company, today announced the closing of its $32 million Series A financing.
The company has provided automated histology for over 1000 customers in academia and industry and built PathologyMapTM, an intelligent tissue platform that hosts the world's largest preclinical pathology database. By focusing on automation and AI, HistoWiz turns tissue specimens into publication quality digital slides online in as little as 48 hours. PathologyMapTM provides customers with online slide viewing, tagging, storage, collaboration, diagnosis, analysis and the ability to search for pathology data. The round was led by Vivo Capital and included other investors venBio, Asahi Kasei and Jon Oringer.
HistoWiz automates histopathology with rapid turnaround time for researchers in academia, biotech and pharma. The company processes tissue specimens and digitizes the results, hosting client's data on a proprietary platform, PathologyMapTM. This online platform contains the largest collection of preclinical pathology data crowdsourced from the scientific community and the first network of top pathologists for on-demand diagnosis. Through automation and AI, HistoWiz aims to become the global leader in histopathology to accelerate cancer research and drug discovery.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about